Effect of recombinant interleukin 5 on the generation of cytotoxic T cells (CTL)
- 1 April 1991
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 133 (2), 317-326
- https://doi.org/10.1016/0008-8749(91)90107-m
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Interleukin 5 enhances interleukin 2-mediated lymphokine-activated killer activity.The Journal of Experimental Medicine, 1989
- Interleukin 5 is a differentiation factor for cytotoxic T lymphocytesImmunology Letters, 1989
- Interleukin-2: Inception, Impact, and ImplicationsScience, 1988
- Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformantsNature, 1988
- Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors.The Journal of Experimental Medicine, 1988
- T cell replacing factor/interleukin 5 induces not only B-cell growth and differentiation, but also increased expression of interleukin 2 receptor on activated B-cellsImmunology Letters, 1987
- Interleukin 2 high-affinity receptor expression requires two distinct binding proteins.The Journal of Experimental Medicine, 1987
- Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assaysEuropean Journal of Immunology, 1987
- Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A.The Journal of Experimental Medicine, 1986
- Antigen stimulation of cytolytic T lymphocyte precursors: minimal requirements for growth and acquisition of cytolytic activityEuropean Journal of Immunology, 1985